2-[4-(Benz­yloxy)benzyl­idene]malononitrile

In the title mol­ecule, C17H12N2O, the dihedral angle between the two benzene rings is 84.98 (10)°. The dicyano­ethyl­ene group is coplanar with the benzene ring to which it is bonded. No classic hydrogen bonds were found in the crystal

High Activity Mutants of Butyrylcholinesterase for Cocaine Hydrolysis

Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (−)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (−)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration

High Activity Mutants of Butyrylcholinesterase for Cocaine Hydrolysis

Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (−)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (−)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration

High Activity Mutants of Butyrylcholinesterase for Cocaine Hydrolysis

Butyrylcholinesterase (BChE) polypeptide variants of the presently-disclosed subject matter have enhanced catalytic efficiency for (−)-cocaine, as compared to wild-type BChE. Pharmaceutical compositions of the presently-disclosed subject matter include a BChE polypeptide variant having an enhanced catalytic efficiency for (−)-cocaine. A method of the presently-disclosed subject matter for treating a cocaine-induced condition includes administering to an individual an effective amount of a BChE polypeptide variant, as disclosed herein, to lower blood cocaine concentration

rac-(S)-2-(1H-Imidazol-1-yl)-3-methyl­butan-1-ol

In the crystal structure of the title compound, C8H14N2O, inter­molecular O—H⋯N hydrogen bonds link mol­ecules related by translation along the a axis into chains. Weak inter­molecular C—H⋯O hydrogen bonds and C—H⋯π inter­actions enhance the crystal packing stability

Cocaine Hydrolase-Fc Fusion Proteins for Cocaine and Methods for Utilizing the Same

The presently-disclosed subject matter includes isolated polypeptides that comprise a butyrylcholinestrase (BChE) polypeptide and a second polypeptide. The BChE polypeptide as well as the second polypeptide can be variants and/or fragments thereof. The presently-disclosed subject matter also includes a pharmaceutical composition that comprises the present isolated polypeptide and a suitable pharmaceutical carrier. Further still, methods are provided for treating cocaine-induced conditions, and comprise administering the isolated polypeptide and/or pharmaceutical compositions thereof to an individual

Multiwavelength Analysis of a Nearby Heavily Obscured AGN in NGC 449

We presented the multiwavelength analysis of a heavily obscured active galactic nucleus (AGN) in NGC 449. We first constructed a broadband X-ray spectrum using the latest NuSTAR and XMM-Newton data. Its column density ($\simeq 10^{24} \rm{cm}^{-2}$) and photon index ($\Gamma\simeq 2.4$) were reliably obtained by analyzing the broadband X-ray spectrum. However, the scattering fraction and the intrinsic X-ray luminosity could not be well constrained. Combined with the information obtained from the mid-infrared (mid-IR) spectrum and spectral energy distribution (SED) fitting, we derived its intrinsic X-ray luminosity ($\simeq 8.54\times 10^{42} \ \rm{erg\ s}^{-1}$) and scattering fraction ($f_{\rm{scat}}\simeq 0.26\%$). In addition, we also derived the following results: (1). The mass accretion rate of central AGN is about $2.54 \times 10^{-2} \rm{M}_\odot\ \rm{yr}^{-1}$, and the Eddington ratio is $8.39\times 10^{-2}$; (2). The torus of this AGN has a high gas-to-dust ratio ($N_{\rm H}/A_{\rm V}=8.40\times 10^{22}\ \rm{cm}^{-2}\ \rm{mag}^{-1}$); (3). The host galaxy and the central AGN are both in the early stage of co-evolution.Comment: 12 pages, 5 figures, 3 tables, Accepted to PAS